NSE: HNDFDS · BSE: 519126 · ISIN INE254N01026
Hindustan Foods Limited stock analysis
Hindustan Foods Limited ranks #2443 in the TickerSutra evidence-ranked universe with a score of 46/100 and 91% data confidence. The latest captured fundamentals show ROCE of 14.1%, quarterly sales growth of 17.9% and quarterly profit growth of 32.8%.Avoid / exit review
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- 17.8% three-year sales CAGR
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- Debt/equity is above 0.5×
- CFO/EBITDA is below 0.6×
- Valuation is above 40× earnings
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹2,040cr | ₹113cr | ₹45cr | 6.0% |
| 2023 | ₹2,598cr | ₹173cr | ₹71cr | 7.0% |
| 2024 | ₹2,755cr | ₹222cr | ₹93cr | 8.0% |
| 2025 | ₹3,639cr | ₹300cr | ₹115cr | 8.0% |
| 2026 | ₹4,251cr | ₹363cr | ₹149cr | 9.0% |
| TTM | ₹4,400cr | ₹380cr | ₹158cr | 9.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
Change in designation of Mr. Shashi Kalathil from Independent Director to Non-Executive Non- Independent Director.
RoutineResignationNSE · 23 Sept 2026Hindustan Foods Limited has informed the Exchange regarding Resignation of Mr Nikhil Vora as Non- Executive Director of the company w.e.f. September 23, 2026.
RoutineHindustan Foods Ltd - 519126 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · 23 Sept 2026Please refer to the attached PDF file.
RoutineHindustan Foods Ltd - 519126 - Board Meeting Outcome for Outcome Of Board MeetingBSE · 23 Sept 2026This is to inform you that the Board of Directors of the Company at its Meeting held today i.e. Wednesday, September 23, 2026 has inter alia transacted the Businesses as per attached PDF file.
RoutineShareholders meetingNSE · 23 Sept 2026Hindustan Foods Limited has informed the Exchange regarding summary of the Proceedings of 41st Annual General Meeting of the Members of the Company held on September 23, 2026
MANAGEMENT COMMENTARY
Signals from filed documents
We enhanced our in-house capabilities, improved process controls and upgraded key production and support areas, enabling greater operational efficiency. Project Progress Project Capex Remarks Capacity expansion in North and South India Rs. In progress Outlook We are expanding capacity across North and South India and are targeting a turnover of Rs.
An extended summer supported robust seasonal demand, improved throughput and sustained customer traction across key markets. During the year, the stick manufacturing facility commenced commercial production, enhancing backward integration and adding an important capability to the ice cream Project Progress Project Capex Remarks Panipat Plant Rs. Phase 1 commercialised Nashik Plant Rs.
Within our Ice Cream business, we commissioned the Panipat [Haryana] manufacturing facility in less than 10 months, demonstrating strong execution capabilities. At the same time, we enhanced backward integration by acquiring a Waffle Cones manufacturing unit and commissioning an Ice Cream Sticks production facility. These initiatives strengthened supply chain efficiency while providing greater operational control.
Furthermore, our Footwear division achieved an important milestone by reaching operational stability. While the business delivered a strong performance, it encountered some margin pressure towards the end of the year due to higher petrochemical prices arising from geopolitical developments. We also continued to strengthen our shared manufacturing platform, with its contribution to total EBITDA increasing to 26% in FY
As the investments we have made begin to mature, we expect them to translate into stronger profitability and improved capital productivity. We remain confident of delivering a Profit After Tax in the range of Rs. in FY 2026-2027, while continuing to uphold the financial discipline that has always guided our decisions.
By contrast, home and personal care categories recorded slower volume growth because of greater exposure to pricing adjustments. Small and medium-sized manufacturers also continued to outpace larger players in volume growth, reflecting their agility in responding to evolving consumer preferences, pricing trends, and local market opportunities. (Source: https://nielseniq.com/global/en/news-center/2026/ niq-gst-2-0-tran
Within health care, we continue to strengthen our capabilities by adding new customers across syrup, tablets and lozenges while progressing our ayurvedic wellness expansion at Baddi. We also initiated the certification process for Class III medical devices at our Chennai facility, which will support our expansion into regulated international markets over time. We are actively pursuing new export opportunities for our
Urbanisation and Appliance Adoption Driving Home Care Evolution Rapid urbanisation and increasing adoption of modern household appliances are transforming the home care segment. Greater penetration of dishwashers and automatic washing machines has boosted demand for specialised products, including liquid detergents, fabric conditioners, dishwasher tablets and other high-performance cleaning solutions. Consumers are a
During FY 2025-2026, the vertical strengthened its position through focused investments, world-class compliance standards and a strategic expansion into the wellness and Ayurvedic segments. The division successfully cleared audits by global regulators, including the US FDA and the Russian FDA, reinforcing its credibility as a trusted manufacturing partner. Capital allocation remained focused on expanding our Healthca
Total income for the quarter stood at INR1,207 crores, registering a growth of 18% over the corresponding quarter last year. EBITDA increased by 26% year-on-year to INR106.3 crores, reflecting improving operating leverage and better asset utilization across our manufacturing platform. Profit before tax grew 33% year -on-year to INR56.6 crores, while profit after tax increased -- also increased 33% to INR42.8 crores,
Higher crude oil-linked raw material prices, packaging costs, freight expenses, and supply chain disruptions have significantly increased operating costs. Manufacturers of soaps, detergents, shampoos, and other personal care products are expected to face the greatest pressure because crude oil-derived inputs account for a significant share of their raw material costs. Despite this, volume growth is expected to moderate
Their ability to respond quickly to evolving preferences and maintain close customer relationships strengthens their competitive position. Consequently, contract manufacturers serving national and multinational FMCG brands may face pricing pressure, fluctuating demand, and market share challenges in regions where local players maintain a strong presence. Intellectual Property Infringement Outsourcing production to thi
MANAGEMENT PROMISE LEDGER
Quantified statements on the clock
“After having executed the record capex in financial year '26, it appears that FY '27 will be larger than the previous year. Supported by improving utilization of recently commissioned capacities, healthy execution across our project pipeline and sustained operating leverage, we remain confident of delivering our FY '27 profit after tax guidance of INR200 crores to INR220 crores, representing the healthy growth of 34%”
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…